ES2076178T3 - Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el. - Google Patents

Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el.

Info

Publication number
ES2076178T3
ES2076178T3 ES89114142T ES89114142T ES2076178T3 ES 2076178 T3 ES2076178 T3 ES 2076178T3 ES 89114142 T ES89114142 T ES 89114142T ES 89114142 T ES89114142 T ES 89114142T ES 2076178 T3 ES2076178 T3 ES 2076178T3
Authority
ES
Spain
Prior art keywords
dna
proteins coded
human papilomavirus
human
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89114142T
Other languages
English (en)
Inventor
Villiers Ethel-Michele De
Anja Hirsch-Behnam
Hausen Harald Prof Dr Dr Zur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2076178T3 publication Critical patent/ES2076178T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Silicon Polymers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

EL INVENTO DESCRIBE EL AISLAMIENTO DEL VIRUS DE PAPILLON HUMANO (HPV)57, EL CARACTERIZADO PARCIAL DE SU GENOMA, ASI COMO SU CLANADO EN PVC 19. DE ESTA FORMA SE ABRE EL CAMINO A DISAGNOSTICO DE TUMORES (ORALES, GENITALES Y DE PIEL), EN TANTO ESTEN ASOCIADOS CON EL PHV57.
ES89114142T 1988-08-06 1989-08-01 Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el. Expired - Lifetime ES2076178T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3826793A DE3826793A1 (de) 1988-08-06 1988-08-06 Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine

Publications (1)

Publication Number Publication Date
ES2076178T3 true ES2076178T3 (es) 1995-11-01

Family

ID=6360384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89114142T Expired - Lifetime ES2076178T3 (es) 1988-08-06 1989-08-01 Papilomavirus humano tipo 57, su adn y las proteinas codificadas por el.

Country Status (9)

Country Link
US (3) US5187090A (es)
EP (1) EP0354440B1 (es)
JP (1) JP3016794B2 (es)
AT (1) ATE124991T1 (es)
AU (1) AU623424B2 (es)
CA (1) CA1339268C (es)
DE (2) DE3826793A1 (es)
ES (1) ES2076178T3 (es)
FI (1) FI98467C (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3722968A1 (de) * 1987-07-11 1989-01-19 Behringwerke Ag Humaner papillomvirus typ 41, seine dna und die dafuer kodierenden proteine
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
CA2365901A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US7704965B2 (en) * 2002-06-26 2010-04-27 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
JP4498357B2 (ja) 2003-09-25 2010-07-07 サード・ウェーブ・テクノロジーズ・インク Ｈｐｖの検出法
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
CA2799205A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337336C (en) * 1987-05-26 1995-10-17 Attila T. Lorincz Human papillomavirus nucleic acid hybridization probes and methods for employing the same

Also Published As

Publication number Publication date
US5618694A (en) 1997-04-08
JPH02150278A (ja) 1990-06-08
US5187090A (en) 1993-02-16
AU3929589A (en) 1990-02-08
ATE124991T1 (de) 1995-07-15
FI98467B (fi) 1997-03-14
DE3826793A1 (de) 1990-03-08
FI893683L (fi) 1990-02-07
DE58909339D1 (de) 1995-08-17
FI893683A0 (fi) 1989-08-03
FI98467C (fi) 1997-06-25
AU623424B2 (en) 1992-05-14
US6127164A (en) 2000-10-03
EP0354440A1 (de) 1990-02-14
JP3016794B2 (ja) 2000-03-06
EP0354440B1 (de) 1995-07-12
CA1339268C (en) 1997-08-12

Similar Documents

Publication Publication Date Title
ES2039233T3 (es) Procedimientos para la produccion de glicoproteinas del citomegalovirus humano (hcmv), anticuerpos correspondientes y vacunas del hcmv, y vectores recombinantes para los mismos.
ATE114169T1 (de) Morphogenetisches knochenprotein.
ATE371670T1 (de) Reinigung von neurotrophinen
ATE123806T1 (de) Genetisch geformte neue pflanzenphenotypen.
DE69133593D1 (de) Menschliches CNP-Gen und Vorläuferprotein
ATE407949T1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
FI884924A7 (fi) Yhdistelmä-DNA-tekniikalla tuotettuja ihmisimmunoglobuliineja
EP0273716A3 (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
IT8723261A0 (it) Innaffiatoio del tipo ondeggiante oscillante regolabile.
DE3672950D1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
ES2006476A6 (es) Un procedimiento para obtener interleukin-2 humana
ES2058479T3 (es) Compuestos peptidicos.
FI896017A7 (fi) Proteiini G-variantin kloonattuja geenejä ja niiden ilmentämiä proteii ni G-variantteja
DE69921180D1 (de) Künstliche matrix-anheftungsregion zur erhöhung der expression von in pflanzen eingeführten genen
DE3785526D1 (de) Auf druck ansprechende schalter erhoehter langlebigkeit.
DE60126602D1 (de) Neue collectine
DE58909339D1 (de) Humaner Papillomvirus Typ 57, seine DNA und die davon kodierten Proteine.
PT714441E (pt) Alergenios recombinantes de cladosporium herbarum
TR199802300T2 (xx) �nsan G proteini �3 alt-birimindeki bir gendeki genetik d�n���m�n hastal�klar�n te�hisi i�in kullan�lmas�.
EP1007647A4 (en) PRODUCTION OF THE INGAP PROTEIN WITH A HIGH EXPRESSION RATE
ATE275207T1 (de) Dna zur abschätzung des progressionspotentials von zervixläsionen
Marusic Purification of specific DNA binding proteins from human cells

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354440

Country of ref document: ES